Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double‐masked, vehicle‐controlled study

Purpose To evaluate topical dexamethasone ophthalmic suspension OCS‐01 (Oculis SA, Lausanne, Switzerland) in diabetic macular edema (DME). Methods This was a multicenter, double‐masked, parallel‐group, randomized, Phase 2 study. Patients aged 18–85 years with DME of

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta ophthalmologica (Oxford, England) England), 2023-02, Vol.101 (1), p.22-33
Hauptverfasser:	Stefansson, Einar, Loftsson, Thorstein, Larsen, Michael, Papp, András, Kaarniranta, Kai, Munk, Marion R., Dugel, Pravin, Tadayoni, Ramin
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors clinical trials cyclodextrin Dexamethasone Diabetes Diabetes Mellitus diabetic macular edema Diabetic Retinopathy - complications Diabetic Retinopathy - diagnosis Diabetic Retinopathy - drug therapy Edema formulation technology Humans Intravitreal Injections Macula Lutea Macular Edema - diagnosis Macular Edema - drug therapy Macular Edema - etiology Steroids Tomography, Optical Coherence - methods Topical medication topical treatment Treatment Outcome Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Purpose To evaluate topical dexamethasone ophthalmic suspension OCS‐01 (Oculis SA, Lausanne, Switzerland) in diabetic macular edema (DME). Methods This was a multicenter, double‐masked, parallel‐group, randomized, Phase 2 study. Patients aged 18–85 years with DME of
ISSN:	1755-375X 1755-3768
DOI:	10.1111/aos.15215